MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$13,563,834
Net operating loss
before income tax...
-$13,563,834
Unrealized gain on digital
assets at fair value
$295,180
Interest and dividend
income, net
$109,491
Other income
$20,000
Operating loss
-$13,988,505
Research and development
expenses
$7,810,337
General and
administrative expenses
$6,178,168
Back
Back
Income Statement
source: myfinsight.com
Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals, Inc. (PCSA)